Skip to Main content Skip to Navigation
Journal articles

Certificates of analysis: a challenge to interpret

Abstract : The active pharmaceutical ingredient (API) in a medicinal product is the component that is responsible for the therapeutic effect. The personnel at the ANSES Fougères Laboratory routinely handle medicinal analytical standard and calculate their API content using the certificates of analysis provided by the manufacturer. However, meaningful data in these documents are not always easy to determine or may sometimes be absent: interpretation of these data can therefore result in assessment errors. Having identified this problem, the ANSES Laboratory has put forward an approach aimed at harmonising interpretation of certificates of analysis.
Document type :
Journal articles
Complete list of metadata
Contributor : Emmanuelle Chiffoleau Connect in order to contact the contributor
Submitted on : Monday, May 7, 2018 - 5:04:51 PM
Last modification on : Friday, April 8, 2022 - 5:45:23 PM
Long-term archiving on: : Tuesday, September 25, 2018 - 3:38:04 PM


Publisher files allowed on an open archive




Catherine Creff-Froger, Mélaine Bessiral, Marie-Pierre Fourmond, Céline Hedou, Agnès Perrin-Guyomard. Certificates of analysis: a challenge to interpret . EuroReference - Les Cahiers de la Référence, ANSES, 2017, pp.27-34. ⟨10.5281/zenodo.1172022⟩. ⟨anses-01787685⟩



Record views


Files downloads